Natcon Biolifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 M
as on 23-10-2024
- Satisfied Charges ₹ 1.50 M
as on 23-10-2024
- Revenue -13.32%
(FY 2023)
- Profit -193.18%
(FY 2023)
- Ebitda -170.93%
(FY 2023)
- Net Worth -33.05%
(FY 2023)
- Total Assets -36.02%
(FY 2023)
About Natcon Biolifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.50 M. The company has closed loans amounting to ₹1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nishant Kumar and Prabhat Singh serve as directors at the Company.
- CIN/LLPIN
U73100DL2009PTC192389
- Company No.
192389
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2009
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Natcon Biolifesciences Private Limited offer?
Natcon Biolifesciences Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Plant Extracts, Herbal Extracts, Root and Vegetable Extracts, Fruit Extracts, Floral Extract, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Herbs,Sticks and Roots.
Who are the key members and board of directors at Natcon Biolifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishant Kumar  | Director | 20-Jul-2009 | Current |
| Prabhat Singh | Director | 20-Jul-2009 | Current |
Financial Performance of Natcon Biolifesciences.
Natcon Biolifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.32% decrease. The company also saw a substantial fall in profitability, with a 193.18% decrease in profit. The company's net worth observed a substantial decline by a decrease of 33.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Natcon Biolifesciences?
In 2023, Natcon Biolifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Galencia Health Care Private LimitedActive 16 years 11 monthsNishant Kumar and Prabhat Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 17 Jan 2023 | ₹2.50 M | Open |
Canara Bank Creation Date: 17 Dec 2021 | ₹2.50 M | Open |
Canara Bank Creation Date: 17 Dec 2021 | ₹2.50 M | Open |
How Many Employees Work at Natcon Biolifesciences?
Natcon Biolifesciences has a workforce of 21 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natcon Biolifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natcon Biolifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
